Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol for general anesthesia in esophagectomy
ChiCTR2200064049Phase 4Not yet recruiting
- Sponsor
- Henan Cancer Hospital
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in esophageal cancer (2 arms), sponsored by Henan Cancer Hospital. Primary endpoint: Intraoperative plasma cortisol, epinephrine, norepinephrine, and serum TNF-α, IL-6, IL-10 concentrations. Planned start Jan 2021; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on ChiCTR2200064049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200064049.